Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.546    -0.034 (-5.86%)
Bid:
0.55
Ask:
0.60
Spread: 0.05 (9.091%)
Market Cap: £3.17m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Blocklisting Interim Review

23 Nov 2015 15:42

RNS Number : 6661G
Futura Medical PLC
23 November 2015
Ā 

23 November 2015

Ā 

Ā 

Ā 

Futura Medical plc

("Futura" or "the Company")

Ā 

Block Listing Update

Ā 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in May 2015, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans. All ordinary shares of 0.2 pence each.

The table below provides further detail.

Ā 

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")EMI Share Option Scheme ("EMI")

Ā 

Period of return:

From:

12 May 2015

To:

23 November 2015

Ā 

Number and class of securities not issued under the scheme(s)

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

Ā 

Ā 

Number of securities issued under the scheme(s) during the period

Ā 

Ā 

Number of securities lapsed under the scheme(s) during the period

USOS:

Nil

EMI:

Ā 

Ā 

USOS:

EMI:

Ā 

Ā 

Nil

Ā 

Ā 

Nil

Nil

Ā 

Ā 

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

Ā 

Number and class of securities originally admitted and the date of admission

USOS:

814,424 on 25 May 2011 and 1,202,280 on 8 October 2013

USOS Total:

Ā 

2,016,704

EMI:

1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013

EMI Total:

2,988,296

Total:

5,005,000

Ā 

Ā 

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

Ā 

Ā 

For further information please contact:

Ā 

Futura Medical plc

Ā 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

Ā 

N+1 Singer (Nominated Adviser and Broker)

Ā 

Aubrey Powell / Liz Yong / Tom SmaleCorporate Finance

Ā 

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

Ā 

Buchanan

Ā 

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000

Ā 

Ā 

Notes to Editors

Ā 

Futura Medical plc

Ā 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Ā 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
BLREXLFLEFFXFBX
Date   Source Headline
13th Dec 20199:05 amRNSSecond Price Monitoring Extn
13th Dec 20199:00 amRNSPrice Monitoring Extension
10th Dec 20194:40 pmRNSSecond Price Monitoring Extn
10th Dec 20194:35 pmRNSPrice Monitoring Extension
10th Dec 201911:05 amRNSSecond Price Monitoring Extn
10th Dec 201911:00 amRNSPrice Monitoring Extension
10th Dec 20199:05 amRNSSecond Price Monitoring Extn
10th Dec 20199:00 amRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSTop Line Results from MED2005 Phase 3 study
6th Dec 20194:10 pmRNSBlock Listing Six Monthly Return
22nd Nov 201911:48 amRNSHolding(s) in Company
20th Nov 20194:05 pmRNSHolding(s) in Company
20th Nov 20194:04 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSPublishes Fireside Chat with Prof Wayne Hellstrom
11th Nov 201912:44 pmRNSHolding(s) in Company
29th Oct 201910:03 amRNSHolding(s) in Company
28th Oct 20194:12 pmRNSMED2005 Safety and Efficacy Data Reported at SMSNA
23rd Oct 201912:46 pmRNSChange of Auditor
21st Oct 20197:00 amRNSFinal Dosing of Last Patient in MED2005 Ph3 study
15th Oct 20195:44 pmRNSFutura Medical to Present Data on MED2005 at SMSNA
15th Oct 20195:42 pmRNSDirector / PCA Shareholding
18th Sep 20195:42 pmRNSDirector/PDMR Shareholding
16th Sep 201910:11 amRNSHolding(s) in Company
13th Sep 20194:40 pmRNSSecond Price Monitoring Extn
13th Sep 20194:35 pmRNSPrice Monitoring Extension
13th Sep 201911:46 amRNSHolding(s) in Company
12th Sep 20199:05 amRNSSecond Price Monitoring Extn
12th Sep 20199:00 amRNSPrice Monitoring Extension
11th Sep 20194:40 pmRNSSecond Price Monitoring Extn
11th Sep 20194:35 pmRNSPrice Monitoring Extension
11th Sep 20197:00 amRNSInterim Results for Six Months ended 30 June 2019
10th Sep 20197:00 amRNSFutura Announces Joint Venture Collaboration
16th Aug 20194:37 pmRNSHolding(s) in Company
12th Aug 20193:21 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSNotice of Interim Results
23rd Jul 20192:06 pmRNSSecond Price Monitoring Extn
23rd Jul 20192:00 pmRNSPrice Monitoring Extension
5th Jul 20193:54 pmRNSHolding(s) in Company
28th Jun 20194:40 pmRNSSecond Price Monitoring Extn
28th Jun 20194:36 pmRNSPrice Monitoring Extension
25th Jun 20194:47 pmRNSDirector/PDMR Shareholding
24th Jun 20194:42 pmRNSAGM Statement
24th Jun 20197:00 amRNSAGM Statement
19th Jun 20197:00 amRNSRecruitment completed for MED2005 Phase 3 study
30th May 20197:00 amRNSBlock listing Interim Review
30th May 20197:00 amRNSNotice of AGM
29th May 201910:47 amRNSHolding(s) in Company
23rd May 20197:00 amRNSLiberum Appointed as Nominated Adviser & Broker
8th May 20192:05 pmRNSSecond Price Monitoring Extn
8th May 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.